These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11195055)

  • 1. Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases?
    Lelongt B; Legallicier B; Piedagnel R; Ronco PM
    Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):7-12. PubMed ID: 11195055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the type IV collagenase system during mouse kidney development and tubule segmentation.
    Legallicier B; Trugnan G; Murphy G; Lelongt B; Ronco P
    J Am Soc Nephrol; 2001 Nov; 12(11):2358-2369. PubMed ID: 11675412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular expression of matrix metalloproteinases in AL-amyloidosis and association with renal function at the time of kidney biopsy.
    Charitaki E; Kastritis E; Petraki C; Liapis K; Adamidis K; Apostolou T; Christodoulidou C; Nikolopoulou N; Terpos E; Nakopoulou L; Dimopoulos MA
    Clin Nephrol; 2016 Jan; 85(1):44-54. PubMed ID: 26587779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis.
    Urushihara M; Kagami S; Kuhara T; Tamaki T; Kuroda Y
    Nephrol Dial Transplant; 2002 Jul; 17(7):1189-96. PubMed ID: 12105240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries.
    Jeyabalan A; Novak J; Danielson LA; Kerchner LJ; Opett SL; Conrad KP
    Circ Res; 2003 Dec; 93(12):1249-57. PubMed ID: 14593002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis.
    Itoh T; Matsuda H; Tanioka M; Kuwabara K; Itohara S; Suzuki R
    J Immunol; 2002 Sep; 169(5):2643-7. PubMed ID: 12193736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression.
    Bauvois B
    Biochim Biophys Acta; 2012 Jan; 1825(1):29-36. PubMed ID: 22020293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury.
    Corbel M; Boichot E; Lagente V
    Braz J Med Biol Res; 2000 Jul; 33(7):749-54. PubMed ID: 10881049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
    Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
    Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection.
    Laplante A; Liu D; Demeule M; Annabi B; Murphy GF; Daloze P; Chen H; Béliveau R
    Transpl Int; 2003 Apr; 16(4):262-9. PubMed ID: 12730807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gelatinases A and B and their endogenous regulators in the corpus uteri in squamous cell cervical carcinoma].
    Timoshenko OS; Gureeva TA; Kugaevskaya EV; Zavalishina LE; Andreeva YY; Solovyeva NI
    Arkh Patol; 2018; 80(6):22-28. PubMed ID: 30585589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
    J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular expression of matrix metalloproteinases in systemic lupus erythematosus in association with activity index and renal function.
    Adamidis KN; Kopaka ME; Petraki C; Charitaki E; Apostolou T; Christodoulidou C; Nikolopoulou N; Giatromanolaki A; Vargemesis V; Passadakis P
    Ren Fail; 2019 Nov; 41(1):229-237. PubMed ID: 30973283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of taurine against renal ischemia/reperfusion injury in rats by inhibition of gelatinases, MMP-2 and MMP-9, and p38 mitogen-activated protein kinase signaling.
    Cavdar Z; Ural C; Celik A; Arslan S; Terzioglu G; Ozbal S; Yildiz S; Ergur UB; Guneli E; Camsari T; Akdogan G
    Biotech Histochem; 2017; 92(7):524-535. PubMed ID: 28895768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-regulated balance between gelatinases and tissue inhibitor (TIMP-1) in isolated human glomeruli.
    Zaoui P; Barro C; Maynard C; Descotes JL; Maurizi-Balzan J; Cordonnier DJ; Morel F
    Ren Fail; 1998 Mar; 20(2):201-9. PubMed ID: 9574444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases and TIMPS in cultured C57BL/6J-cpk kidney tubules.
    Rankin CA; Suzuki K; Itoh Y; Ziemer DM; Grantham JJ; Calvet JP; Nagase H
    Kidney Int; 1996 Sep; 50(3):835-44. PubMed ID: 8872958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats.
    Schaefer L; Han X; August C; Matzkies F; Lorenz T; Schaefer RM
    Diabetologia; 1997 Sep; 40(9):1035-43. PubMed ID: 9300240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural alterations of the vascular wall in magnesium-deficient mice. A possible role of gelatinases A (MMP-2) and B (MMP-9).
    Pagès N; Gogly B; Godeau G; Igondjo-Tchen S; Maurois P; Durlach J; Bac P
    Magnes Res; 2003 Mar; 16(1):43-8. PubMed ID: 12735482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease.
    Chen NX; O'Neill KD; Chen X; Kiattisunthorn K; Gattone VH; Moe SM
    Am J Nephrol; 2011; 34(3):211-9. PubMed ID: 21791917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
    Tanney DC; Feng L; Pollock AS; Lovett DH
    Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.